Galectin Therapeutics Ownership | Who Owns Galectin Therapeutics?

Galectin Therapeutics Ownership Summary

Galectin Therapeutics is owned by 16.18% institutional investors, 31.24% insiders, and 52.58% retail investors. Vanguard group is the largest institutional shareholder, holding 3.43% of GALT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.06% of its assets in Galectin Therapeutics shares.

GALT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Galectin Therapeutics	16.18%	31.24%	52.58%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	2.14M	3.43%	$2.76M
Blackrock funding, inc. /de	1.65M	2.65%	$2.13M
Blackrock	1.56M	2.52%	$3.53M
Advisor group	1.18M	1.90%	$3.25M
Geode capital management	870.59K	1.40%	$1.12M
Wealthspire advisors	398.37K	0.64%	$513.90K
Geneos wealth management	388.94K	0.62%	$501.73K
State street	229.62K	0.37%	$518.93K
Morgan stanley	227.22K	0.37%	$513.51K
Atria wealth solutions	207.10K	0.33%	$267.16K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Retirement guys formula	155.34K	0.10%	$200.39K
Solutions 4 wealth	36.00K	0.08%	$46.44K
Cutter & co brokerage	115.49K	0.04%	$148.98K
Geneos wealth management	388.94K	0.02%	$501.73K
Soltis investment advisors	140.75K	0.02%	$181.57K
Vivaldi capital management lp	45.63K	0.01%	$55.67K
Advisor group	1.18M	0.01%	$3.25M
Wealthspire advisors	398.37K	0.01%	$513.90K
Scientech research	13.35K	0.00%	$17.22K
Two sigma securities	28.57K	0.00%	$36.86K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	1.56M	0.00%	851.14K
Retirement guys formula	155.34K	0.10%	91.53K
State street	229.62K	-	68.17K
Blackrock funding, inc. /de	1.65M	-	44.77K
Morgan stanley	227.22K	-	42.53K

Top Sellers

Holder	Shares	% Assets	Change
Commonwealth equity services	134.52K	0.00%	-348.75K
Susquehanna group, llp	10.25K	-	-71.21K
Marshall wace, llp	-	-	-52.26K
Jane street group	-	-	-36.78K
Exoduspoint capital management, lp	-	-	-29.55K

New Positions

Holder	Shares	% Assets	Change	Value
Two sigma securities	28.57K	0.00%	28.57K	$36.86K
Hightower advisors	22.49K	-	22.49K	$29.01K
Gsa capital partners llp	21.53K	0.00%	21.53K	$28.00K
Pnc financial services group	20.00K	-	20.00K	$25.80K
Hrt financial lp	19.54K	0.00%	19.54K	$25.00K

Sold Out

Holder	Change
Group one trading	-542.00
Russell investments group	-740.00
Meeder asset management	-3.82K
Wolverine trading	-10.90K
Y-intercept (hong kong)	-11.14K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	110	23.60%	10,078,323	3.40%	16	6.61%	64	64.10%	9	-50.00%
Sep 30, 2024	87	14.47%	9,657,327	1.46%	15	6.57%	39	-11.36%	17	112.50%
Jun 30, 2024	76	22.58%	9,518,560	24.93%	15	9.58%	44	100.00%	8	-20.00%
Mar 31, 2024	62	-8.82%	7,618,819	7.06%	12	8.91%	22	22.22%	10	-33.33%
Dec 31, 2023	68	13.33%	7,116,188	-20.56%	11	5.27%	18	20.00%	15	66.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.29M	2.06%	42.35K
Vanguard US Total Market Shares ETF	1.25M	1.97%	-
Vanguard Institutional Extnd Mkt Idx Tr	670.16K	1.07%	-
iShares Russell 2000 ETF	379.36K	0.60%	-3.30K
Fidelity Extended Market Index	268.67K	0.43%	-1.71K
Fidelity Small Cap Index	187.14K	0.30%	-3.50K
iShares Russell 2000 Growth ETF	106.59K	0.17%	-508.00
Vanguard Russell 2000 ETF	93.01K	0.15%	2.16K
BlackRock Extended Equity Market K	92.01K	0.15%	-39.00
Extended Equity Market Fund K	91.04K	0.14%	279.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 30, 2024	Shlevin Harold H.	-	Buy	$7.54K
Dec 23, 2024	Jamil Khurram	Chief Medical Officer	Sell	$12.04K
Dec 23, 2024	LEWIS JOEL	President and CEO	Sell	$49.61K
Dec 23, 2024	CALLICUTT JACK W	Chief Financial Officer	Sell	$35.49K
Dec 24, 2024	Zordani Richard A. Jr.	-	Buy	$8.16K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	8	3
2024 Q3	4	-
2024 Q2	4	2
2024 Q1	2	-

GALT Ownership FAQ

Who Owns Galectin Therapeutics?

Galectin Therapeutics shareholders are primarily institutional investors at 16.18%, followed by 31.24% insiders and 52.58% retail investors. The average institutional ownership in Galectin Therapeutics's industry, Biotech Stocks , is 68.48%, which Galectin Therapeutics falls below.

Who owns the most shares of Galectin Therapeutics?

Galectin Therapeutics’s largest shareholders are Vanguard group (2.14M shares, 3.43%), Blackrock funding, inc. /de (1.65M shares, 2.65%), and Blackrock (1.56M shares, 2.52%). Together, they hold 8.61% of Galectin Therapeutics’s total shares outstanding.

Does Blackrock own Galectin Therapeutics?

Yes, BlackRock owns 2.52% of Galectin Therapeutics, totaling 1.56M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.53M$. In the last quarter, BlackRock increased its holdings by 851.14K shares, a 119.44% change.

Who is Galectin Therapeutics’s biggest shareholder by percentage of total assets invested?

Retirement guys formula is Galectin Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.10% of its assets in 155.34K Galectin Therapeutics shares, valued at 200.39K$.

Who is the top mutual fund holder of Galectin Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Galectin Therapeutics shares, with 2.06% of its total shares outstanding invested in 1.29M Galectin Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools